|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Gastrointestinal cancer
Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital
Min Hyun Kim, Duck-Woo Kim, Hye Seung Lee, Su Kyung Bang, Soo Hyun Seo, Kyung Un Park, Heung-Kwon Oh, Sung-Bum Kang
Cancer Res Treat.
2023;55(1):179-188. Published online March 21, 2022 DOI:
https://doi.org/10.4143/crt.2021.1512
Web of Science 4
Crossref 5
Targeting Hypoxia Using Evofos
fam
ide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
Jeesun Yoon, Seo Young Kang, Kyung-Hun Lee, Gi Jeong Cheon, Do-Youn Oh
Cancer Res Treat.
2021;53(2):471-479. Published online October 22, 2020 DOI:
https://doi.org/10.4143/crt.2020.577
Web of Science 2
Crossref 2
Gynecologic cancer
Uptake of
Fam
ily-Specific Mutation Genetic Testing Among Relatives of Patients with Ovarian Cancer with
BRCA1
or
BRCA2
Mutation
Go Woon Jeong, Wonkyo Shin, Dong Ock Lee, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim
Cancer Res Treat.
2021;53(1):207-211. Published online August 11, 2020 DOI:
https://doi.org/10.4143/crt.2020.364
Web of Science 7
Crossref 6
Prevalence of
PALB2
Germline Mutations in Early-onset and
Fam
ilial Breast/Ovarian Cancer Patients from Pakistan
Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann
Cancer Res Treat.
2019;51(3):992-1000. Published online October 11, 2018 DOI:
https://doi.org/10.4143/crt.2018.356
Web of Science 7
Crossref 8
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Web of Science 12
Crossref 10
Patient’s Cognitive Function and Attitudes towards
Fam
ily Involvement in Cancer Treatment Decision Making: A Patient-
Fam
ily Caregiver Dyadic Analysis
Dong Wook Shin, Juhee Cho, Debra L. Roter, So Young Kim, Jong Hyock Park, Hyung Kook Yang, Hyun Woo Lee, Sun-Seog Kweon, Yune Sik Kang, Keeho Park
Cancer Res Treat.
2018;50(3):681-690. Published online July 4, 2017 DOI:
https://doi.org/10.4143/crt.2017.201
Web of Science 17
Crossref 17
Identification of Diverse Adenosine-to-Inosine RNA Editing Subtypes in Colorectal Cancer
Si-Hyun Lee, Hwang-Phill Kim, Jun-Kyu Kang, Sang-Hyun Song, Sae-Won Han, Tae-You Kim
Cancer Res Treat.
2017;49(4):1077-1087. Published online January 25, 2017 DOI:
https://doi.org/10.4143/crt.2016.301
Web of Science 19
Crossref 21
Clinically Significant Unclassified Variants in
BRCA1
and
BRCA2
Genes among Korean Breast Cancer Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2017;49(3):627-634. Published online September 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.292
Web of Science 12
Crossref 10
The Prevalence of Founder Mutations among Individuals from
Fam
ilies with
Fam
ilial Pancreatic Cancer Syndrome
Marcin R. Lener, Aniruddh Kashyap, Wojciech Kluźniak, Cezary Cybulski, Agnieszka Soluch, Sandra Pietrzak, Tomasz Huzarski, Jacek Gronwald, Jan Lubiński
Cancer Res Treat.
2017;49(2):430-436. Published online July 28, 2016 DOI:
https://doi.org/10.4143/crt.2016.217
Web of Science 18
Crossref 18
Association between Health Behaviors and a
Fam
ily History of Cancer among Korean Women
Youngsun Ham, Hea Young Oh, Sang-Soo Seo, Mi Kyung Kim
Cancer Res Treat.
2016;48(2):806-814. Published online September 22, 2015 DOI:
https://doi.org/10.4143/crt.2015.083
Web of Science 5
Crossref 7
Clinical Characteristics and Adequate Treatment of
Fam
ilial Adenomatous Polyposis Combined with Desmoid Tumors
Won Beom Jung, Chan Wook Kim, Jin Cheon Kim
Cancer Res Treat.
2014;46(4):366-373. Published online August 25, 2014 DOI:
https://doi.org/10.4143/crt.2013.185
Web of Science 9
Crossref 10
Psychosocial Impact of Cancer Patients on Their
Fam
ily Members
Sun Min Lim, Hyeon Chang Kim, Soohyeon Lee
Cancer Res Treat.
2013;45(3):226-233. Published online September 30, 2013 DOI:
https://doi.org/10.4143/crt.2013.45.3.226
Crossref 19
Fatal Ifos
fam
ide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases
You-Jung Shin, Ji-Young Kim, Jei-Won Moon, Rae-Mi You, Jeong-Yeol Park, Joo-Hyun Nam
Cancer Res Treat.
2011;43(4):260-263. Published online December 27, 2011 DOI:
https://doi.org/10.4143/crt.2011.43.4.260
Crossref 18
Reversible Proximal Renal Tubular Dysfunction after One-Time Ifos
fam
ide Exposure
Young Il Kim, Ju Young Yoon, Jun Eul Hwang, Hyun Jeong Shim, Woo Kyun Bae, Sang Hee Cho, Ik-Joo Chung
Cancer Res Treat.
2010;42(4):244-246. Published online December 31, 2010 DOI:
https://doi.org/10.4143/crt.2010.42.4.244
Crossref 4
A Phase II Trial of Docetaxel and Ifos
fam
ide for Patients with Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Gyeong-Won Lee, Jung-Hun Kang, Seok-Hyun Kim, Hea Yong Lee, Ho-Cheol Kim, Won-Sup Lee, Jong-Duk Lee, Young-Sil Hwang, Joung-Soon Jang, Jong-Seok Lee
Cancer Res Treat.
2004;36(5):287-292. Published online October 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.5.287
Crossref 1
Oral Etoposide, Ifos
fam
ide and Cisplatin in the Treatment of Extensive Disease Small Cell Lung Cancer
Seok Jin Kim, Hwa Jung Sung, Kyong Hwa Park, So Young Yoon, Sang Cheul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Kwang Taek Kim, Young Ho Choi, Jun Suk Kim
Cancer Res Treat.
2002;34(6):421-425. Published online December 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.6.421
A Phase II Study of Ifos
fam
ide, Carboplatin, and Epirubicin (ICE) Combination Chemotherapy for Extensive Disease of Small Cell Lung Cancer
Jae Ho Byun, In Sook Woo, Hun Ho Song, Keun Seok Lee, Jin Seok Ahn, Dae Young Jang, Jung Ae Lee, Young Lee Park, Young Suk Park
Cancer Res Treat.
2002;34(6):416-420. Published online December 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.6.416
Effect of Vinorelbine, Ifos
fam
ide and Cisplatin Combination Chemotherapy in Stage III-IV Non-Small-Cell Lung Cancer
Young Chul Kim, So Young Lee, Hong Joo Cho, Jung A Kim, So Hyang Song, Chi Hong Kim, Hoon Kyo Kim, Meyung Im Ahn, Jin Young You, Sung Whan Kim, Deng Gon Cho, Kyu Do Cho, Jin Hyung Kang
Cancer Res Treat.
2002;34(5):352-356. Published online October 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.5.352
MINE (mesna, ifos
fam
ide, mitoxantrone, etoposide) Chemotherapy as a Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Seong Hoon Chang, Yang Soo Kim, Wan Kyu Eo
Cancer Res Treat.
2002;34(2):145-152. Published online April 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.2.145
Crossref 1
Expression of High Mobility Group Protein
Fam
ily [HMGI(Y) and HMGI-C] in Human Breast Cancer
Jin Woo Ryu, Duck Hwan Kim, Hyung Sik Shin, Eun Sook Nam, Hyung Jee Kim
Cancer Res Treat.
2001;33(4):281-285. Published online August 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.4.281
Crossref 2
Combination Chemotherapy with Vinorelbine and Ifos
fam
ide in Patients with Advanced Non-Small Cell Lung Cancer
Seong Geun Kim, Sung Hyun Kim, Hyuk Chan Kwon, Kee Hyun Lee, Jae Seok Kim, Hyo Jin Kim
J Korean Cancer Assoc.
2001;33(2):163-167.
Phase I Clinical Trial of Paclitaxel Plus Ifos
fam
ide for the Patients with Refractory Ovarian Cancer
Ho Sawk Saw, Jae Kwan Lee
J Korean Cancer Assoc.
2000;32(5):895-903.
Efficacy of Combination Chemotherapy with Vinorelbine, Ifos
fam
ide, and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
Heung Moon Chang, Jung Ae Lee, Jin Seok Ahn, In Sook Woo, Young Iee Park, Jee Woong Son, Seung Joon Lee, Dong Kyu Kim, Eun Kyung Mo, Myung Jae Park, Myung Goo Lee, In Gyu Hyun, Ki Suck Jung, Young Suk Park
J Korean Cancer Assoc.
2000;32(3):612-618.
Combination Chemotherapy with VP - 16 , Ifos
fam
ide , and Cisplatin ( VIP ) in the Advanced Non - Small Cell Lung Cancer
Yong Seon Cho, Si Young Kim, Jeong Hee Kim, Hwi Joong Yoon, Kyung Sam Cho
J Korean Cancer Assoc.
2000;32(1):86-92.
The Effect of Combination Chemotherapy with Vinorelbine, Carboplatin, and Ifos
fam
ide in Patients with Advanced Non-Small Cell Lung Cancer
Young Woo Lee, Baek Yeol Ryoo, Tae You Kim, Bong Seog Kim, Yeon Hee Park, Hyun Ju Hong, Jin Young Kwag, Sang Won Lee, Yoon Koo Kang
J Korean Cancer Assoc.
1999;31(6):1227-1235.
A Phase 2 Study with Vinorelbine and Ifos
fam
ide in the Inoperable Non - small Cell Lung Cancer
Moon Hee Lee, Young Jin Yoo, Soo Mi Bang, Gyung Hae Joung, Hyo Jin Kim, Dong Bok Shin, Soon Nam Lee, Seong Rok Kim, Dae Seog Heo, Yung Jue Bang, Noe Kyeong Kim
J Korean Cancer Assoc.
1999;31(5):972-978.
Combination Chemotherapy with Cisplatin, Ifos
fam
ide, and Etoposide in Small Cell Lung Cancer
In Keun Choi, Byung Soo Kim, Jae Jeong Shim, Sang Won Shin, Yeul Hong Kim, Kyung Ho Kang, Kwang Taek Kim, Jun Suk Kim, Young Ho Choi
J Korean Cancer Assoc.
1999;31(4):692-698.
Combination Chemotherapy with Etoposide, Ifos
fam
ide, and Cisplatin (VIP) in Small Cell Lung Cancer
Goon Jae Cho, Joo Seop Chung, Ihm Soo Kwak, Ha Yeon Rha
J Korean Cancer Assoc.
1999;31(3):539-547.
A Phase 2 Study of VP-16 , Ifos
fam
ide , and Cisplatin ( VIP ) Combination Chemotherapy Plus Concurrent Thoracic Irradiation for Limited Small Cell Lung Cancer
Seok Ah Im, Moon Hee Lee, Chul Won Jung, Dae Seog Heo, Yung Jue Bang, Young Soo Shim, Chan Il Park, Noe Kyeong Kim
J Korean Cancer Assoc.
1999;31(2):306-312.
Clinical Efficacy of Combination Chemotherapy with Cisplatin , Ifos
fam
ide , and Oral Etoposide ( PIE ) in Advanced Non - Small Cell Lung Cancer
Yeul Hong Kim, Jae Hong Seo, Byung Soo Kim, Sang Won Shin, Jae Jung Shin, Kyung Ho Kang, Young Ho Choi, Kwang Tak Kim, Jun Suk Kim
J Korean Cancer Assoc.
1999;31(2):297-305.
1
2
Journal Impact Factor 4.1